126 related articles for article (PubMed ID: 2435259)
1. Carcinoembryonic antigen and milk-fat globule protein staining of malignant mesothelioma and adenocarcinoma of the lung.
Tron V; Wright JL; Churg A
Arch Pathol Lab Med; 1987 Mar; 111(3):291-3. PubMed ID: 2435259
[TBL] [Abstract][Full Text] [Related]
2. Antigenic phenotype of malignant mesotheliomas and pulmonary adenocarcinomas. An immunohistologic analysis demonstrating the value of Leu M1 antigen.
Sheibani K; Battifora H; Burke JS
Am J Pathol; 1986 May; 123(2):212-9. PubMed ID: 2422942
[TBL] [Abstract][Full Text] [Related]
3. The immunohistochemical diagnosis of mesothelioma. Differentiation of mesothelioma and lung adenocarcinoma.
Ordóñez NG
Am J Surg Pathol; 1989 Apr; 13(4):276-91. PubMed ID: 2648877
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of membranous staining of mesothelioma.
King JA; Tucker JA
Cell Vis; 1998; 5(1):24-7. PubMed ID: 9660721
[TBL] [Abstract][Full Text] [Related]
5. Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma.
Comin CE; Novelli L; Boddi V; Paglierani M; Dini S
Hum Pathol; 2001 May; 32(5):529-36. PubMed ID: 11381372
[TBL] [Abstract][Full Text] [Related]
6. Immunohistological study of malignant diffuse mesotheliomas of the pleura.
Loosli H; Hurlimann J
Histopathology; 1984 Sep; 8(5):793-803. PubMed ID: 6083969
[TBL] [Abstract][Full Text] [Related]
7. Mesothelioma: profile of keratin proteins and carcinoembryonic antigen: an immunoperoxidase study of 20 cases and comparison with pulmonary adenocarcinomas.
Corson JM; Pinkus GS
Am J Pathol; 1982 Jul; 108(1):80-8. PubMed ID: 6178295
[TBL] [Abstract][Full Text] [Related]
8. [A comparison of the sialyl SSEA-1 antigen and CEA in the histology of malignant mesothelioma, with special reference to adenocarcinoma of the lung].
Kishimoto T; Okada K; Shimamoto F; Sato T; Ono T
Gan No Rinsho; 1988 Nov; 34(14):1951-5. PubMed ID: 2462647
[TBL] [Abstract][Full Text] [Related]
9. Distinction of mesothelioma from adenocarcinoma. An immunohistochemical approach.
Battifora H; Kopinski MI
Cancer; 1985 Apr; 55(8):1679-85. PubMed ID: 2579718
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical differentiation of malignant mesothelioma, mesothelial hyperplasia and metastatic adenocarcinoma in serous effusions, utilizing staining for carcinoembryonic antigen, keratin and vimentin.
Duggan MA; Masters CB; Alexander F
Acta Cytol; 1987; 31(6):807-14. PubMed ID: 2447718
[TBL] [Abstract][Full Text] [Related]
11. The distinction of adenocarcinoma from malignant mesothelioma in cell blocks of effusions: the role of routine mucin histochemistry and immunohistochemical assessment of carcinoembryonic antigen, keratin proteins, epithelial membrane antigen, and milk fat globule-derived antigen.
Cibas ES; Corson JM; Pinkus GS
Hum Pathol; 1987 Jan; 18(1):67-74. PubMed ID: 2434407
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal anti-CEA antibodies in the discrimination between primary pulmonary adenocarcinoma and colon carcinoma metastatic to the lung.
Ghoneim AH; Brisson ML; Fuks A; Mobasher AA; Kreisman H
Mod Pathol; 1990 Sep; 3(5):613-8. PubMed ID: 2235987
[TBL] [Abstract][Full Text] [Related]
13. Immunocytological staining reactions of anti-carcinoembryonic antigen, Ca, and anti-human milk fat globule monoclonal antibodies on benign and malignant exfoliated mesothelial cells.
Ghosh AK; Butler EB
J Clin Pathol; 1987 Dec; 40(12):1424-7. PubMed ID: 3323250
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical evaluation of seven monoclonal antibodies for differentiation of pleural mesothelioma from lung adenocarcinoma.
Wirth PR; Legier J; Wright GL
Cancer; 1991 Feb; 67(3):655-62. PubMed ID: 1702354
[TBL] [Abstract][Full Text] [Related]
15. Immunohistological staining of reactive mesothelium, mesothelioma, and lung carcinoma with a panel of monoclonal antibodies.
Ghosh AK; Gatter KC; Dunnill MS; Mason DY
J Clin Pathol; 1987 Jan; 40(1):19-25. PubMed ID: 2434531
[TBL] [Abstract][Full Text] [Related]
16. The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions.
Shield PW; Koivurinne K
Cytopathology; 2008 Aug; 19(4):218-23. PubMed ID: 17916095
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of PAS-diastase and carcinoembryonic antigen staining in the differential diagnosis of malignant mesothelioma and papillary serous carcinoma of the ovary.
Silcocks PB; Herbert A; Wright DH
J Pathol; 1986 Jun; 149(2):133-41. PubMed ID: 2426430
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical evaluation of pleural mesothelioma and pulmonary adenocarcinoma. A bi-institutional study of 47 cases.
Otis CN; Carter D; Cole S; Battifora H
Am J Surg Pathol; 1987 Jun; 11(6):445-56. PubMed ID: 2438954
[TBL] [Abstract][Full Text] [Related]
19. Carcinoembryonic antigen (CEA) and gastrointestinal cancer associated antigen CA 19-9 in bronchioloalveolar carcinomas and pulmonary adenocarcinomas.
Heikkilä L; Suomalainen RJ; Lindgren J; Jalanko H; Harjula A; Mattila S
Ann Chir Gynaecol; 1986; 75(5):260-5. PubMed ID: 3030184
[TBL] [Abstract][Full Text] [Related]
20. Immunocytochemistry in the differential diagnosis of effusions: use of logistic regression to select a panel of antibodies to distinguish adenocarcinomas from mesothelial proliferations.
Frisman DM; McCarthy WF; Schleiff P; Buckner SB; Nocito JD; O'Leary TJ
Mod Pathol; 1993 Mar; 6(2):179-84. PubMed ID: 8483888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]